| First Author | Narducci MG | Year | 1997 |
| Journal | Oncogene | Volume | 15 |
| Issue | 8 | Pages | 919-26 |
| PubMed ID | 9285687 | Mgi Jnum | J:42464 |
| Mgi Id | MGI:1095787 | Doi | 10.1038/sj.onc.1201246 |
| Citation | Narducci MG, et al. (1997) The murine Tcl1 oncogene: embryonic and lymphoid cell expression. Oncogene 15(8):919-26 |
| abstractText | In human leukemias and lymphomas nonrandom chromosomal rearrangements cause changes in cell growth and/or survival in such a way as to promote malignancy. The detailed study of the biochemical and genetic pathways altered in human cancer requires the identification or development of models to allow the study and manipulation of cancer gene function. Recently, the breakpoint gene TCL1, involved in chromosome translocations observed mostly in mature T-cell proliferations and chronic lymphocytic leukemias (CLL), was isolated and characterized, and showed to be part of a new gene family of proteins involved in these tumors. The murine Tcl1 gene, is similar in sequence to the murine and human MTCP1 gene also involved in T cell leukemias. The murine Tcl1 gene was shown to reside on mouse chromosome 12 in a region syntenic to human chromosome 14. Furthermore, we show that the murine Tcl1 gene is expressed early in mouse embryonic development and demonstrates expression in fetal hematopoietic organs as well as in immature T and B cells. Characterization of the murine Tcl1 gene will help in developing a mouse model of CLL and would provide the best opportunity to study and decipher the role of TCL1 in malignant transformation. |
